Consistent with the high expression of FBXO22 in human MLLr AML cells, we demonstrated that FBXO22 was also highly expressed in mouse GFP+ leukemia cells from a MLL-AF9-induced AML model [33], as determined by Western blot (Additional file 4: Fig. S3A). This evidence concerns the gene KMT2A and acute myeloid leukemia.